Who is

We are a dynamic global provider of high quality services in the field of drug testing, clinical studies and bioanalytical services. Our goal and ethos is to ensure that your medicinal products reach the market in time, in the highest quality and exactly to your specifications.
– Roman Grunt, CEO

Quinta is an innovative and trusted world leader in pharmaceutical analysis, R&D and clinical testing in both human and veterinary medicinal products.

Offering a range of services spanning the whole pharmaceutical spectrum, Quinta possesses unrivaled expertise across analytical services, clinical studies and more.

Proudly based in Central Europe, with partners in the EU, US and Asia, Quinta has 250 experienced in-house professionals ready to support your projects.

Our Team. Our Values.

Our approach stems from having some of the most experienced and talented scientists on the planet within our team forming a true center of excellence. We combine an inimitable mix of the sophistication of modern pharmaceutical practice, with the experience of leading industry experts.
The result: quintessence.


Roman Grunt graduated from Czech Technical University in Prague, Faculty of Mechanical Engineering, and London Business School, where he studied Corporate Finance. Since 1996, he worked at Ernst & Young in Prague and Zurich.

In 2000, he held several financial positions at Zentiva, participated in acquisitions in Slovakia, Romania and Turkey. During 2008, he became the CFO of Eczacibasi-Zentiva Turkey. Later, during 2010, he joined CEZ Turkey as the CFO. In autumn 2013, he became the General Director of the company FARMAK and since 2017, he has held the position of CEO of QUINTA-ANALYTICA.


Marcela Písačková studied chemistry at Charles University in Prague. She has completed a course Qualified person in the pharmaceutical industry and postgraduate courses Good Control Laboratory Practice and Pharmaceutical Analytical Control.

She joined QUINTA-ANALYTICA in 1999 as a research worker and has since gained experience in many professional positions including a project coordinator and the Head of quality assurance. Since 2017, she has held the position of the Director of Operations responsible for pharmaceutical and bioanalytical analyses.


Jiří Raška is a graduate of Physical Chemistry from the University of Pardubice, where he also later completed his doctoral studies in the same field. From 2004 he worked as Head of QC in the pharmaceutical manufacturing company Contipro Group.

From 2006-2008 he was Head of QC and Project Manager with the service provider Lunaria. From 2008–2013 he was Chief Production Officer and Commercial Director at IREL. From 2013-2018 he was Commercial Director of Czech based company FARMAK, manufacturer of APIs and intermediates for pharmaceutical industry. Since 2018 Jiří has been working for QUINTA-ANALYTICA as Chief Commercial Officer and is responsible for the company’s business and marketing activities.


Martin Mička graduated from the University of Economics in Prague, Faculty of International Relations, with a minor specialization in Faculty of Business Administration. Since 2003 he held different senior financial positions in Zentiva Czech Republic, participated in the first IPO in Eastern Europe.

In 2009 he joined bio-pharmaceutical company Actelion as Finance manager for Czech & Slovak Republic and since 2015 he worked as CEO. From September 2022 he took over the position of CFO at QUINTA-ANALYTICA.


Robert Khaddour graduated from the University of Chemistry and Technology Prague, Faculty of Electrical Engineering. From 2001, he worked as a computer network administrator at the Institute of plasma physics.

He joined QUINTA-ANALYTICA in 2002 as an IT manager and later became the Head of the technical department.